BioElectronics Corporation Receives FDA Reclassification Recommendation
BioElectronics Corporation BIEL is a development and manufacturing company of several medical products including: HealFast®, RecoverRx®, and Allay®. The company is a worldwide leader in proprietary healthcare technologies, and has recently received a recommendation of reclassification from the FDA. The proposed change would reclassify current company Class III device standings of shortwave diathermy technologies to Class II nonthermal shortwave therapy certifications.
View full press release